17 Oct 2022 by admin in UncategorizedComments Kira Pharmaceuticals Announces IND Approval from Chinese NMPA for Phase 2 Evaluation of KP104 in Paroxysmal Nocturnal Hemoglobinuria (PNH)
03 Oct 2022 by admin in UncategorizedComments Kira Pharmaceuticals Receives FDA Clearance of IND Application for Phase 2 Evaluation of KP104 in Systemic Lupus Erythematosus Associated Thrombotic Microangiopathy (SLE-TMA)
21 Sep 2022 by admin in UncategorizedComments OriCell Therapeutics Receives Implied License from NMPA for Ori-C101 IND Application
16 Sep 2022 by admin in UncategorizedComments Syros Announces Closing of Merger with Tyme Technologies and Concurrent Private Placement
15 Sep 2022 by admin in UncategorizedComments Syros and Tyme Technologies Announce Stockholder Approval of Merger
07 Sep 2022 by admin in UncategorizedComments Zenas BioPharma Appoints Simon Lowry, M.D. as Chief Medical Officer
31 Aug 2022 by admin in UncategorizedComments Innoforce, Mayo Clinic & Hibiscus BioVentures launch Mayflower BioVentures
15 Aug 2022 by admin in UncategorizedComments Adicet Reports Second Quarter 2022 Financial Results and Provides Business Updates
08 Aug 2022 by admin in UncategorizedComments Design Therapeutics Highlights Upcoming Milestones and Reports Second Quarter 2022 Financial Results
